- $52.80m
- $28.54m
- $90.50m
Pulmonx Corp reports results for the quarter ended in December - Earnings Summary
Pulmonx Corp expected to post a loss of 42 cents a share - Earnings Preview
Brief: Steven A. Cohen Reports 5.3 Percent Passive Stake In Pulmonx Corporation As Of Jan 3, 2023 - SEC Filing
Pulmonx up on Japan's approval of lung device
Brief: Pulmonx Receives Japanese Approval Of Severe Copd/Emphysema Treatment
Pulmonx crashes to all-time low on dour FY outlook, Q3 revenue miss
Pulmonx Corp reports results for the quarter ended in September - Earnings Summary
Pulmonx Corp expected to post a loss of 40 cents a share - Earnings Preview
Refinitiv Newscasts - Asia Insight: China's exports gain steam but outlook cloudy as global growth cools
Brief: Pulmonx Q2 Revenue Rose 14 Percent To $14 Million
Pulmonx Corp expected to post a loss of 41 cents a share - Earnings Preview
Pulmonx Corp reports results for the quarter ended in March - Earnings Summary
Brief: Pulmonx Reports Q1 Loss Per Share Of $0.43
Pulmonx Corp expected to post a loss of 37 cents a share - Earnings Preview
Pulmonx Corp reports results for the quarter ended in December - Earnings Summary
Brief: Pulmonx Reports Q4 And Full Year 2021 Financial Results
Pulmonx Corp expected to post a loss of 36 cents a share - Earnings Preview
Brief: Pulmonx Posts Q3 Loss Per Share Of $0.28
Pulmonx Corp expected to post a loss of 37 cents a share - Earnings Preview